| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 22 | 2015 | 3408 | 1.600 |
Why?
|
| Genes, Immunoglobulin | 17 | 2000 | 283 | 1.430 |
Why?
|
| B-Lymphocytes | 29 | 2013 | 4787 | 1.420 |
Why?
|
| Chemokines, CXC | 10 | 2007 | 420 | 1.330 |
Why?
|
| Immunoglobulin Variable Region | 15 | 1999 | 419 | 1.180 |
Why?
|
| Focal Adhesion Kinase 1 | 5 | 2012 | 120 | 1.180 |
Why?
|
| Stem Cell Niche | 4 | 2017 | 346 | 1.050 |
Why?
|
| Immunoglobulin Heavy Chains | 15 | 2000 | 647 | 0.990 |
Why?
|
| Lymphopoiesis | 3 | 2012 | 133 | 0.860 |
Why?
|
| Hematopoiesis | 12 | 2020 | 2060 | 0.830 |
Why?
|
| Bone Marrow | 11 | 2020 | 2926 | 0.820 |
Why?
|
| Agglutinins | 13 | 1995 | 28 | 0.790 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 5 | 2009 | 183 | 0.770 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 14 | 1995 | 147 | 0.730 |
Why?
|
| Chemotaxis | 8 | 2016 | 598 | 0.700 |
Why?
|
| Receptors, CXCR4 | 6 | 2007 | 729 | 0.570 |
Why?
|
| Blood Transfusion | 7 | 2020 | 1308 | 0.540 |
Why?
|
| Autoantibodies | 15 | 2000 | 2115 | 0.520 |
Why?
|
| Rh-Hr Blood-Group System | 9 | 2018 | 64 | 0.490 |
Why?
|
| Cell Adhesion | 9 | 2009 | 3093 | 0.480 |
Why?
|
| Platelet Transfusion | 3 | 2016 | 301 | 0.450 |
Why?
|
| Erythrocytes | 9 | 2018 | 2412 | 0.450 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 6 | 1999 | 89 | 0.450 |
Why?
|
| Receptors, Chemokine | 3 | 2006 | 652 | 0.450 |
Why?
|
| Chemokine CXCL12 | 11 | 2015 | 457 | 0.450 |
Why?
|
| Kell Blood-Group System | 1 | 2013 | 21 | 0.440 |
Why?
|
| Bone Marrow Cells | 8 | 2017 | 2413 | 0.420 |
Why?
|
| Neutrophils | 10 | 2021 | 3782 | 0.420 |
Why?
|
| Isoantibodies | 3 | 2013 | 681 | 0.420 |
Why?
|
| Lymphoma, AIDS-Related | 3 | 2000 | 79 | 0.410 |
Why?
|
| Arterioles | 1 | 2013 | 252 | 0.410 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2005 | 240 | 0.400 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2017 | 1664 | 0.400 |
Why?
|
| Anemia, Hemolytic | 1 | 2013 | 164 | 0.400 |
Why?
|
| Immunoglobulin M | 11 | 2006 | 1527 | 0.390 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 6 | 2021 | 633 | 0.380 |
Why?
|
| Colony-Forming Units Assay | 4 | 2013 | 351 | 0.370 |
Why?
|
| Blood Platelets | 5 | 2018 | 2465 | 0.350 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 230 | 0.340 |
Why?
|
| Granulocytes | 4 | 2017 | 551 | 0.330 |
Why?
|
| Complement C3a | 2 | 2005 | 66 | 0.310 |
Why?
|
| I Blood-Group System | 5 | 1995 | 8 | 0.310 |
Why?
|
| Blood Group Antigens | 4 | 2015 | 183 | 0.290 |
Why?
|
| Plasma Exchange | 6 | 1987 | 160 | 0.280 |
Why?
|
| Immunoglobulin Idiotypes | 6 | 1995 | 200 | 0.280 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2007 | 99 | 0.280 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2009 | 429 | 0.280 |
Why?
|
| Antigens, Human Platelet | 2 | 2018 | 41 | 0.280 |
Why?
|
| Models, Animal | 1 | 2013 | 2121 | 0.270 |
Why?
|
| Myeloid Cells | 7 | 2017 | 838 | 0.270 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 178 | 0.270 |
Why?
|
| PTEN Phosphohydrolase | 6 | 2015 | 1117 | 0.260 |
Why?
|
| Cell Cycle | 6 | 2013 | 2925 | 0.250 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 258 | 0.250 |
Why?
|
| Animals | 58 | 2021 | 168939 | 0.250 |
Why?
|
| Peritonitis | 3 | 2020 | 368 | 0.240 |
Why?
|
| Cell Separation | 6 | 2017 | 1718 | 0.240 |
Why?
|
| RGS Proteins | 1 | 2005 | 76 | 0.240 |
Why?
|
| Receptors, Complement | 1 | 2005 | 254 | 0.240 |
Why?
|
| Mice | 46 | 2021 | 81898 | 0.230 |
Why?
|
| Blood Grouping and Crossmatching | 6 | 2018 | 99 | 0.230 |
Why?
|
| Bone Marrow Transplantation | 8 | 2024 | 2730 | 0.230 |
Why?
|
| Myeloma Proteins | 2 | 1995 | 71 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2024 | 5753 | 0.220 |
Why?
|
| Cryoglobulins | 11 | 1995 | 58 | 0.220 |
Why?
|
| Escherichia coli Infections | 2 | 2020 | 518 | 0.220 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 205 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 4652 | 0.220 |
Why?
|
| Anemia, Sickle Cell | 2 | 2024 | 1063 | 0.220 |
Why?
|
| Plasmapheresis | 3 | 1991 | 205 | 0.220 |
Why?
|
| Cell Differentiation | 17 | 2020 | 11657 | 0.220 |
Why?
|
| Blood Banks | 3 | 1996 | 108 | 0.210 |
Why?
|
| Transcription Factors | 7 | 2021 | 12159 | 0.210 |
Why?
|
| Base Sequence | 19 | 2005 | 12415 | 0.210 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 4 | 1997 | 110 | 0.210 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1995 | 892 | 0.200 |
Why?
|
| Phosphorylation | 8 | 2010 | 8310 | 0.200 |
Why?
|
| Amino Acid Sequence | 19 | 2021 | 13411 | 0.200 |
Why?
|
| Flow Cytometry | 8 | 2017 | 5890 | 0.200 |
Why?
|
| Stromal Cells | 5 | 2012 | 1334 | 0.190 |
Why?
|
| Leukemia | 2 | 2009 | 1521 | 0.190 |
Why?
|
| Reactive Oxygen Species | 4 | 2017 | 2144 | 0.190 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 661 | 0.190 |
Why?
|
| Mice, Knockout | 14 | 2015 | 14473 | 0.190 |
Why?
|
| Receptors, CCR5 | 2 | 2002 | 491 | 0.180 |
Why?
|
| Molecular Sequence Data | 20 | 1999 | 17609 | 0.180 |
Why?
|
| Splenomegaly | 2 | 2020 | 191 | 0.180 |
Why?
|
| HIV Seropositivity | 2 | 1999 | 962 | 0.180 |
Why?
|
| Fetal Blood | 5 | 2013 | 1367 | 0.180 |
Why?
|
| DNA, Complementary | 6 | 2014 | 1989 | 0.170 |
Why?
|
| Multipotent Stem Cells | 2 | 2012 | 200 | 0.170 |
Why?
|
| Bone Marrow Purging | 3 | 1996 | 108 | 0.170 |
Why?
|
| Blood Component Removal | 3 | 2000 | 124 | 0.170 |
Why?
|
| Integrin alpha4beta1 | 3 | 2012 | 119 | 0.170 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2020 | 122 | 0.170 |
Why?
|
| Adult Stem Cells | 2 | 2013 | 221 | 0.170 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2007 | 692 | 0.170 |
Why?
|
| Embryonic Stem Cells | 2 | 2021 | 1244 | 0.160 |
Why?
|
| Apoptosis | 10 | 2021 | 9514 | 0.160 |
Why?
|
| Cell Death | 4 | 2021 | 1676 | 0.160 |
Why?
|
| Carbohydrates | 2 | 1993 | 387 | 0.160 |
Why?
|
| Humans | 124 | 2024 | 766812 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 7 | 2000 | 1080 | 0.160 |
Why?
|
| Lymphoma, B-Cell | 4 | 1995 | 945 | 0.150 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1998 | 72 | 0.150 |
Why?
|
| Cell Line, Transformed | 6 | 2009 | 861 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 2426 | 0.150 |
Why?
|
| Zinc Fingers | 1 | 2021 | 577 | 0.150 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18986 | 0.150 |
Why?
|
| HIV-2 | 1 | 1999 | 156 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 13 | 2001 | 9244 | 0.150 |
Why?
|
| Hemagglutinins | 2 | 1995 | 111 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 11 | 2017 | 22351 | 0.150 |
Why?
|
| Histone Demethylases | 1 | 2021 | 328 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 1492 | 0.150 |
Why?
|
| Immunoglobulin G | 5 | 2000 | 4559 | 0.150 |
Why?
|
| Multigene Family | 3 | 1999 | 1081 | 0.140 |
Why?
|
| Neutropenia | 2 | 2021 | 895 | 0.140 |
Why?
|
| Hematology | 1 | 2001 | 243 | 0.140 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2017 | 49 | 0.140 |
Why?
|
| Immunoglobulin kappa-Chains | 3 | 1992 | 171 | 0.140 |
Why?
|
| Escherichia coli | 3 | 2020 | 4211 | 0.140 |
Why?
|
| Virus Activation | 1 | 1999 | 322 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 2 | 2012 | 227 | 0.130 |
Why?
|
| Blood Component Transfusion | 2 | 2000 | 141 | 0.130 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 58 | 0.130 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2015 | 112 | 0.130 |
Why?
|
| ABO Blood-Group System | 3 | 2018 | 381 | 0.130 |
Why?
|
| Stem Cell Factor | 2 | 2015 | 194 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 8928 | 0.130 |
Why?
|
| Homeostasis | 5 | 2020 | 3343 | 0.130 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1995 | 347 | 0.130 |
Why?
|
| Integrases | 2 | 2010 | 520 | 0.130 |
Why?
|
| Cell Transformation, Viral | 4 | 1992 | 527 | 0.130 |
Why?
|
| HIV-1 | 3 | 2000 | 6948 | 0.130 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2014 | 325 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2000 | 527 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2009 | 1642 | 0.130 |
Why?
|
| Cyclophosphamide | 5 | 1999 | 2234 | 0.120 |
Why?
|
| Clone Cells | 7 | 1995 | 1670 | 0.120 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 1996 | 546 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1999 | 663 | 0.120 |
Why?
|
| Cloning, Molecular | 7 | 2000 | 4168 | 0.120 |
Why?
|
| Chemokines, CC | 2 | 2006 | 285 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8623 | 0.120 |
Why?
|
| Gammaretrovirus | 1 | 2014 | 24 | 0.120 |
Why?
|
| Radiation Chimera | 2 | 2011 | 216 | 0.120 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2014 | 24 | 0.120 |
Why?
|
| Signal Transduction | 11 | 2016 | 23618 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 9 | 2000 | 6066 | 0.120 |
Why?
|
| Ubiquitination | 2 | 2011 | 1007 | 0.120 |
Why?
|
| Glutathione | 1 | 2017 | 589 | 0.120 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2015 | 163 | 0.120 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1741 | 0.110 |
Why?
|
| Blotting, Southern | 5 | 1992 | 774 | 0.110 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2015 | 201 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2005 | 89 | 0.110 |
Why?
|
| 16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Lymphocytes | 5 | 2012 | 2606 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2000 | 2746 | 0.110 |
Why?
|
| Cold Temperature | 7 | 1993 | 793 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11876 | 0.110 |
Why?
|
| Cell Lineage | 4 | 2013 | 2573 | 0.110 |
Why?
|
| Chemokines | 3 | 2005 | 963 | 0.110 |
Why?
|
| P Blood-Group System | 2 | 1994 | 3 | 0.110 |
Why?
|
| Genes, Reporter | 3 | 2014 | 1525 | 0.110 |
Why?
|
| HIV Core Protein p24 | 1 | 1993 | 245 | 0.110 |
Why?
|
| Spleen | 5 | 2013 | 2295 | 0.110 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1993 | 86 | 0.100 |
Why?
|
| Blood Cells | 2 | 1994 | 309 | 0.100 |
Why?
|
| Antibody Specificity | 6 | 1993 | 1062 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1150 | 0.100 |
Why?
|
| Antigens, Differentiation | 2 | 2014 | 921 | 0.100 |
Why?
|
| Phagocytosis | 2 | 2009 | 1526 | 0.100 |
Why?
|
| Research | 1 | 2001 | 1977 | 0.100 |
Why?
|
| Interleukin-7 | 1 | 2012 | 146 | 0.100 |
Why?
|
| Animals, Congenic | 1 | 2011 | 27 | 0.100 |
Why?
|
| Nitroimidazoles | 1 | 2013 | 118 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2007 | 7869 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 2456 | 0.100 |
Why?
|
| Cell Proliferation | 7 | 2021 | 10451 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2000 | 1998 | 0.100 |
Why?
|
| Immunoblotting | 3 | 2007 | 1647 | 0.100 |
Why?
|
| Immunoprecipitation | 3 | 2009 | 874 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2429 | 0.100 |
Why?
|
| Erythrocyte Membrane | 1 | 1993 | 438 | 0.090 |
Why?
|
| Cyclohexanones | 1 | 2011 | 30 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 1026 | 0.090 |
Why?
|
| Transfection | 5 | 2009 | 5755 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 415 | 0.090 |
Why?
|
| Lymphocyte Activation | 5 | 1996 | 5502 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2021 | 2626 | 0.090 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 630 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2013 | 316 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 1993 | 853 | 0.090 |
Why?
|
| Mice, Inbred NOD | 4 | 2021 | 1836 | 0.090 |
Why?
|
| Bacteriophages | 1 | 1994 | 382 | 0.090 |
Why?
|
| Muscles | 5 | 2002 | 1576 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 572 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 1805 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2005 | 1244 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3600 | 0.090 |
Why?
|
| Rheumatoid Factor | 1 | 1991 | 185 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2012 | 300 | 0.090 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2010 | 58 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1996 | 1374 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 2 | 1999 | 838 | 0.090 |
Why?
|
| Receptors, CCR7 | 2 | 2008 | 105 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 661 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 2631 | 0.080 |
Why?
|
| Femur | 2 | 2013 | 1318 | 0.080 |
Why?
|
| Triterpenes | 1 | 2010 | 78 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 4523 | 0.080 |
Why?
|
| Teratoma | 1 | 2012 | 405 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2014 | 697 | 0.080 |
Why?
|
| Antibodies, Anticardiolipin | 2 | 2000 | 62 | 0.080 |
Why?
|
| RNA Interference | 2 | 2009 | 2829 | 0.080 |
Why?
|
| Multiple Myeloma | 3 | 1995 | 5193 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1965 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2009 | 2470 | 0.080 |
Why?
|
| Leukocytes | 2 | 2000 | 2034 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.080 |
Why?
|
| Receptors, Interleukin-21 | 1 | 2008 | 32 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2021 | 4427 | 0.080 |
Why?
|
| Erythropoietin | 1 | 1993 | 718 | 0.080 |
Why?
|
| Fibrinogen | 2 | 1993 | 893 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 2021 | 6105 | 0.080 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 1987 | 132 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6507 | 0.080 |
Why?
|
| Immunoglobulin A | 1 | 1992 | 992 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2535 | 0.080 |
Why?
|
| Cryopreservation | 4 | 2017 | 727 | 0.080 |
Why?
|
| Gene Expression | 6 | 2014 | 7585 | 0.080 |
Why?
|
| Cysteine | 3 | 2017 | 896 | 0.080 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 269 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9528 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 9613 | 0.080 |
Why?
|
| Cell Line | 10 | 2009 | 15564 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2329 | 0.070 |
Why?
|
| Pneumonia, Bacterial | 1 | 2011 | 319 | 0.070 |
Why?
|
| Inflammation | 3 | 2017 | 10863 | 0.070 |
Why?
|
| Utilization Review | 1 | 1989 | 381 | 0.070 |
Why?
|
| Program Development | 1 | 2014 | 1297 | 0.070 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Leukocyte Transfusion | 2 | 2021 | 58 | 0.070 |
Why?
|
| Refrigeration | 1 | 2007 | 27 | 0.070 |
Why?
|
| Peer Review | 1 | 1989 | 218 | 0.070 |
Why?
|
| Myelopoiesis | 1 | 2008 | 135 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2007 | 110 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2021 | 1604 | 0.070 |
Why?
|
| Antigens, CD34 | 3 | 2014 | 656 | 0.070 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 1997 | 46 | 0.070 |
Why?
|
| Splenectomy | 2 | 1987 | 390 | 0.070 |
Why?
|
| Chemokine CCL19 | 1 | 2006 | 37 | 0.070 |
Why?
|
| Chemokine CCL21 | 1 | 2006 | 49 | 0.070 |
Why?
|
| Amino Acid Motifs | 2 | 2021 | 928 | 0.070 |
Why?
|
| Tissue Adhesives | 1 | 1988 | 177 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 392 | 0.070 |
Why?
|
| T-Lymphocytes | 4 | 2014 | 10263 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4424 | 0.070 |
Why?
|
| Tubulin | 1 | 2010 | 694 | 0.070 |
Why?
|
| Receptors, CXCR5 | 1 | 2006 | 88 | 0.070 |
Why?
|
| Receptors, CCR6 | 1 | 2006 | 73 | 0.070 |
Why?
|
| Blood Preservation | 1 | 2007 | 169 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2008 | 475 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 685 | 0.060 |
Why?
|
| Antigens, Ly | 1 | 2007 | 297 | 0.060 |
Why?
|
| Amniotic Fluid | 1 | 2008 | 381 | 0.060 |
Why?
|
| Anaphylatoxins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 2629 | 0.060 |
Why?
|
| Ear, Middle | 1 | 1988 | 341 | 0.060 |
Why?
|
| Myosins | 2 | 1988 | 407 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2008 | 3587 | 0.060 |
Why?
|
| Cell Division | 5 | 2011 | 4473 | 0.060 |
Why?
|
| Isoelectric Focusing | 3 | 1991 | 148 | 0.060 |
Why?
|
| Galactose | 1 | 2007 | 299 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 434 | 0.060 |
Why?
|
| Cell Movement | 6 | 2013 | 5204 | 0.060 |
Why?
|
| von Willebrand Diseases | 1 | 1987 | 135 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1677 | 0.060 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2005 | 87 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1057 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2000 | 289 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2005 | 72 | 0.060 |
Why?
|
| Cell Migration Inhibition | 1 | 2005 | 97 | 0.060 |
Why?
|
| Phenytoin | 1 | 1986 | 189 | 0.060 |
Why?
|
| Pyridines | 2 | 2021 | 2888 | 0.060 |
Why?
|
| Isoantigens | 2 | 2001 | 562 | 0.060 |
Why?
|
| Mitosis | 1 | 2010 | 1176 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3401 | 0.060 |
Why?
|
| Male | 25 | 2020 | 364154 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 1995 | 2177 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2161 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 712 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2021 | 3073 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 2882 | 0.060 |
Why?
|
| Cell Communication | 1 | 2011 | 1660 | 0.060 |
Why?
|
| Immunization | 1 | 2008 | 1218 | 0.060 |
Why?
|
| Microtubules | 1 | 2010 | 1063 | 0.060 |
Why?
|
| Lentivirus | 1 | 2007 | 518 | 0.060 |
Why?
|
| Lymphoma | 2 | 1993 | 1899 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11924 | 0.060 |
Why?
|
| Glycoproteins | 3 | 2001 | 2201 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1672 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4570 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 616 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1998 | 3803 | 0.050 |
Why?
|
| Chemokine CXCL2 | 2 | 2016 | 105 | 0.050 |
Why?
|
| Adult | 24 | 2018 | 223305 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 723 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 2 | 1995 | 282 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1995 | 1057 | 0.050 |
Why?
|
| Female | 27 | 2020 | 396532 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2013 | 2856 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18329 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 1994 | 411 | 0.050 |
Why?
|
| Oxygen | 1 | 2014 | 4252 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2039 | 0.050 |
Why?
|
| Gene Library | 2 | 1995 | 1065 | 0.050 |
Why?
|
| Graft Survival | 1 | 2013 | 3904 | 0.050 |
Why?
|
| HIV | 2 | 2000 | 1588 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2011 | 3738 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2005 | 539 | 0.050 |
Why?
|
| Transplantation, Autologous | 4 | 1996 | 2127 | 0.050 |
Why?
|
| DNA Primers | 3 | 1995 | 2826 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 2590 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1983 | 325 | 0.050 |
Why?
|
| Breast Neoplasms | 3 | 1999 | 21162 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 1925 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 1990 | 2189 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 419 | 0.050 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 734 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2006 | 2931 | 0.050 |
Why?
|
| Blood Cell Count | 2 | 2008 | 405 | 0.050 |
Why?
|
| Actins | 2 | 2005 | 2061 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1882 | 0.050 |
Why?
|
| Stem Cells | 2 | 2007 | 3536 | 0.050 |
Why?
|
| Fetus | 2 | 1999 | 1878 | 0.050 |
Why?
|
| Blood Substitutes | 1 | 2001 | 57 | 0.050 |
Why?
|
| Protein Binding | 4 | 2021 | 9326 | 0.040 |
Why?
|
| Glycolipids | 2 | 1994 | 203 | 0.040 |
Why?
|
| Tyrosine | 1 | 2005 | 1425 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3723 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2005 | 504 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2011 | 2979 | 0.040 |
Why?
|
| Blast Crisis | 2 | 2011 | 102 | 0.040 |
Why?
|
| Reading Frames | 1 | 1999 | 16 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 9546 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5922 | 0.040 |
Why?
|
| Heart | 1 | 2013 | 4425 | 0.040 |
Why?
|
| Herpesvirus 7, Human | 1 | 1999 | 14 | 0.040 |
Why?
|
| HIV Antigens | 1 | 2000 | 328 | 0.040 |
Why?
|
| Protein Transport | 1 | 2005 | 1944 | 0.040 |
Why?
|
| beta 2-Glycoprotein I | 1 | 1998 | 28 | 0.040 |
Why?
|
| Forecasting | 2 | 2001 | 2936 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2021 | 399 | 0.040 |
Why?
|
| Bone Marrow Neoplasms | 1 | 1999 | 101 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2014 | 657 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4349 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3605 | 0.040 |
Why?
|
| Thiotepa | 2 | 1999 | 66 | 0.040 |
Why?
|
| Oligonucleotides | 2 | 1991 | 561 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2000 | 340 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 11062 | 0.040 |
Why?
|
| Transplantation | 1 | 2000 | 222 | 0.040 |
Why?
|
| Autoantigens | 2 | 1994 | 890 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 1991 | 3079 | 0.040 |
Why?
|
| Models, Biological | 1 | 2014 | 9464 | 0.040 |
Why?
|
| Herpesvirus 6, Human | 1 | 1999 | 96 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 454 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1206 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2008 | 1857 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2005 | 1377 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 1987 | 1076 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 2 | 1988 | 130 | 0.040 |
Why?
|
| Glutaredoxins | 1 | 2017 | 32 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2017 | 5022 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 13644 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4277 | 0.040 |
Why?
|
| Autoimmunity | 2 | 1995 | 1361 | 0.040 |
Why?
|
| Hybridomas | 2 | 1992 | 442 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 1999 | 268 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 93 | 0.030 |
Why?
|
| Herpesvirus 8, Human | 1 | 1999 | 254 | 0.030 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1998 | 166 | 0.030 |
Why?
|
| Pregnancy | 6 | 2013 | 30236 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2011 | 5795 | 0.030 |
Why?
|
| Parental Consent | 1 | 1996 | 63 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1995 | 33 | 0.030 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1995 | 87 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1995 | 58 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1988 | 3464 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2000 | 692 | 0.030 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1995 | 62 | 0.030 |
Why?
|
| Benzamides | 1 | 2021 | 1375 | 0.030 |
Why?
|
| Plasma | 2 | 1989 | 583 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 1999 | 557 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 857 | 0.030 |
Why?
|
| Karyotyping | 2 | 1988 | 1176 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2000 | 1392 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1991 | 3788 | 0.030 |
Why?
|
| Reference Values | 1 | 2002 | 4914 | 0.030 |
Why?
|
| Blood Group Incompatibility | 1 | 1996 | 134 | 0.030 |
Why?
|
| DNA | 4 | 1998 | 7210 | 0.030 |
Why?
|
| Phenotype | 4 | 2005 | 16722 | 0.030 |
Why?
|
| Skin | 1 | 2008 | 4499 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7240 | 0.030 |
Why?
|
| Calcium | 2 | 2000 | 5783 | 0.030 |
Why?
|
| Phospholipids | 1 | 1998 | 778 | 0.030 |
Why?
|
| Cell Survival | 3 | 2014 | 5749 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2014 | 89 | 0.030 |
Why?
|
| Risk Assessment | 1 | 1996 | 24299 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 197 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 313 | 0.030 |
Why?
|
| Infant, Newborn | 6 | 2013 | 26387 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5690 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 1996 | 726 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 705 | 0.030 |
Why?
|
| Neoplasms | 2 | 2021 | 22350 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2008 | 828 | 0.030 |
Why?
|
| Middle Aged | 15 | 2018 | 223267 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 2391 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1994 | 98 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2014 | 158 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2002 | 3642 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 2012 | 0.030 |
Why?
|
| Laser Scanning Cytometry | 1 | 2013 | 5 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 2 | 1989 | 574 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1751 | 0.030 |
Why?
|
| Factor XIII | 1 | 1993 | 59 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 3815 | 0.030 |
Why?
|
| Ligands | 2 | 2016 | 3274 | 0.030 |
Why?
|
| Hemagglutination | 2 | 1992 | 32 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2015 | 277 | 0.030 |
Why?
|
| Hemagglutination Tests | 1 | 1992 | 76 | 0.030 |
Why?
|
| Immunoelectrophoresis | 1 | 1992 | 94 | 0.030 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2013 | 63 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1993 | 274 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1867 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2013 | 58 | 0.030 |
Why?
|
| Sirolimus | 1 | 2000 | 1540 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 949 | 0.030 |
Why?
|
| Acetylcholinesterase | 2 | 1983 | 151 | 0.030 |
Why?
|
| Cardiolipins | 1 | 1992 | 82 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1999 | 3624 | 0.020 |
Why?
|
| Ploidies | 1 | 2013 | 287 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1994 | 446 | 0.020 |
Why?
|
| Epitopes | 1 | 1998 | 2526 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 872 | 0.020 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1993 | 96 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1995 | 748 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1992 | 131 | 0.020 |
Why?
|
| Lung Injury | 1 | 2016 | 432 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 899 | 0.020 |
Why?
|
| HIV Infections | 2 | 1995 | 17532 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1989 | 297 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1756 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 848 | 0.020 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2011 | 37 | 0.020 |
Why?
|
| Transgenes | 1 | 2014 | 1014 | 0.020 |
Why?
|
| Platelet Count | 1 | 1994 | 784 | 0.020 |
Why?
|
| Introns | 1 | 1993 | 966 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17089 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
| Caspases | 1 | 2014 | 881 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2013 | 609 | 0.020 |
Why?
|
| Carboplatin | 1 | 1994 | 790 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 4249 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2013 | 370 | 0.020 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2010 | 36 | 0.020 |
Why?
|
| Education | 1 | 2013 | 531 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1767 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2017 | 1282 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2011 | 280 | 0.020 |
Why?
|
| Proteins | 1 | 2005 | 6002 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 463 | 0.020 |
Why?
|
| Perinatology | 1 | 1990 | 64 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1994 | 1606 | 0.020 |
Why?
|
| Alleles | 3 | 2014 | 6896 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2011 | 425 | 0.020 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 1989 | 91 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2015 | 1144 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 69 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2015 | 1111 | 0.020 |
Why?
|
| United States | 6 | 2014 | 72945 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1990 | 1141 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2009 | 241 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2215 | 0.020 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2009 | 116 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 724 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 3610 | 0.020 |
Why?
|
| Kinetics | 3 | 1986 | 6288 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2012 | 722 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2008 | 116 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 578 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2012 | 876 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2008 | 110 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Tympanoplasty | 1 | 1988 | 73 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1998 | 2841 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 1987 | 1884 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2887 | 0.020 |
Why?
|
| Aged | 8 | 2021 | 171344 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 932 | 0.020 |
Why?
|
| Bleeding Time | 1 | 1987 | 83 | 0.020 |
Why?
|
| Factor VIII | 1 | 1989 | 349 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 2561 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 1987 | 94 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 1140 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4215 | 0.020 |
Why?
|
| Adiposity | 1 | 2017 | 1892 | 0.020 |
Why?
|
| Placenta | 1 | 1996 | 1726 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 677 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1697 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5795 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1986 | 174 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1305 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 364 | 0.020 |
Why?
|
| Blood Volume | 1 | 1988 | 544 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 461 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 1030 | 0.020 |
Why?
|
| Endothelium | 1 | 2009 | 768 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1742 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1990 | 642 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1989 | 676 | 0.020 |
Why?
|
| Lung | 2 | 2016 | 10068 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1512 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 1757 | 0.020 |
Why?
|
| Citrates | 1 | 1986 | 132 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 372 | 0.020 |
Why?
|
| Body Temperature | 1 | 1989 | 780 | 0.020 |
Why?
|
| Shock | 1 | 1988 | 316 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 1988 | 393 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2078 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2007 | 249 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 713 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1622 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 52 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 3321 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 4443 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 961 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1985 | 84 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 1985 | 71 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 2005 | 89 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2204 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4356 | 0.010 |
Why?
|
| Selectins | 1 | 2005 | 101 | 0.010 |
Why?
|
| Osteosclerosis | 1 | 1985 | 41 | 0.010 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1985 | 84 | 0.010 |
Why?
|
| Fever | 1 | 1992 | 1607 | 0.010 |
Why?
|
| Retroviridae | 1 | 2007 | 846 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 4860 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1990 | 1438 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2009 | 736 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 94 | 0.010 |
Why?
|
| Mathematics | 1 | 1986 | 696 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2014 | 1503 | 0.010 |
Why?
|
| Cytarabine | 1 | 1986 | 696 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2015 | 2559 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 8540 | 0.010 |
Why?
|
| Algorithms | 2 | 2018 | 14073 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3759 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1999 | 12795 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1988 | 587 | 0.010 |
Why?
|
| Anemia | 1 | 1993 | 1514 | 0.010 |
Why?
|
| Rubella | 1 | 1984 | 55 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2014 | 65286 | 0.010 |
Why?
|
| Glycosylation | 1 | 2007 | 1099 | 0.010 |
Why?
|
| Quality Control | 1 | 1986 | 834 | 0.010 |
Why?
|
| Regeneration | 1 | 2013 | 1520 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1987 | 350 | 0.010 |
Why?
|
| Interleukins | 1 | 2008 | 796 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7571 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1993 | 1403 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2008 | 706 | 0.010 |
Why?
|
| Resuscitation | 1 | 1988 | 681 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1983 | 34 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1986 | 498 | 0.010 |
Why?
|
| Collagen Diseases | 1 | 1983 | 39 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1995 | 3079 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1986 | 214 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2012 | 4143 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 4114 | 0.010 |
Why?
|
| Monocytes | 1 | 1992 | 2599 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 4853 | 0.010 |
Why?
|
| Mutation | 3 | 2014 | 30214 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 1349 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 1612 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1994 | 3702 | 0.010 |
Why?
|
| Muscle Contraction | 2 | 1988 | 1208 | 0.010 |
Why?
|
| Microsurgery | 1 | 1988 | 798 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 1985 | 194 | 0.010 |
Why?
|
| Gestational Age | 2 | 2008 | 3617 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1983 | 243 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1986 | 1251 | 0.010 |
Why?
|
| DEAE-Cellulose | 1 | 1982 | 1 | 0.010 |
Why?
|
| DEAE-Dextran | 1 | 1982 | 9 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1729 | 0.010 |
Why?
|
| Complement C4 | 1 | 1983 | 216 | 0.010 |
Why?
|
| Internet | 1 | 2014 | 3113 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3582 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1990 | 1158 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2198 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1986 | 1688 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1986 | 1472 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1986 | 1617 | 0.010 |
Why?
|
| Adolescent | 4 | 2018 | 88902 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2591 | 0.010 |
Why?
|
| Cellulose | 1 | 1982 | 116 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 1394 | 0.010 |
Why?
|
| Infant | 2 | 2014 | 36459 | 0.010 |
Why?
|
| Emergencies | 1 | 1988 | 1223 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3796 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1999 | 9407 | 0.010 |
Why?
|
| Recurrence | 1 | 1994 | 8507 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10384 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1993 | 2505 | 0.010 |
Why?
|
| Complement C3 | 1 | 1983 | 434 | 0.010 |
Why?
|
| Time Factors | 2 | 1994 | 40149 | 0.010 |
Why?
|
| Biological Products | 1 | 2010 | 948 | 0.010 |
Why?
|
| Hylobates | 1 | 2000 | 13 | 0.010 |
Why?
|
| Cebus | 1 | 2000 | 15 | 0.010 |
Why?
|
| Neuromuscular Diseases | 1 | 1983 | 260 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6013 | 0.010 |
Why?
|
| Gorilla gorilla | 1 | 2000 | 29 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2008 | 2669 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1982 | 563 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 147 | 0.010 |
Why?
|
| Dextrans | 1 | 1982 | 574 | 0.010 |
Why?
|
| Myocardium | 1 | 2013 | 4765 | 0.010 |
Why?
|
| Risk Factors | 3 | 1992 | 74889 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1985 | 665 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6225 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 1776 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2000 | 224 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2000 | 361 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1986 | 1791 | 0.010 |
Why?
|
| Genetic Variation | 2 | 1992 | 6613 | 0.010 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2000 | 92 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2000 | 211 | 0.010 |
Why?
|
| Integrins | 1 | 2003 | 839 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 2801 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 59939 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 8065 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1985 | 713 | 0.010 |
Why?
|
| Collagen | 1 | 2007 | 2635 | 0.010 |
Why?
|
| Macaca | 1 | 2000 | 413 | 0.010 |
Why?
|
| Hypogonadism | 1 | 1985 | 802 | 0.010 |
Why?
|
| Syndrome | 1 | 1985 | 3271 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 474 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 59548 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 478 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3427 | 0.010 |
Why?
|
| Colitis | 1 | 1986 | 1238 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1987 | 2158 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8045 | 0.010 |
Why?
|
| Hospitals | 1 | 1989 | 3885 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1992 | 3633 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 1730 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5306 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12826 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1987 | 2763 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5513 | 0.010 |
Why?
|
| Public Policy | 1 | 2000 | 551 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1999 | 614 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 1246 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 54872 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5330 | 0.010 |
Why?
|
| Haplotypes | 1 | 2001 | 2726 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1161 | 0.010 |
Why?
|
| Child | 2 | 2013 | 80670 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 996 | 0.010 |
Why?
|
| Immune System | 1 | 2000 | 800 | 0.010 |
Why?
|
| Binding Sites, Antibody | 2 | 1986 | 340 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 1667 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4968 | 0.010 |
Why?
|
| Cholesterol | 1 | 1983 | 2904 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 1788 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13642 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2921 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14653 | 0.010 |
Why?
|
| Europe | 1 | 2000 | 3430 | 0.010 |
Why?
|
| Seizures | 1 | 1986 | 2996 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 5784 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1228 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2000 | 1608 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 3157 | 0.010 |
Why?
|
| Exons | 1 | 1997 | 2392 | 0.010 |
Why?
|
| Mastectomy | 1 | 1999 | 1861 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1999 | 3552 | 0.010 |
Why?
|
| Fetomaternal Transfusion | 1 | 1990 | 10 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3698 | 0.010 |
Why?
|
| Rho(D) Immune Globulin | 1 | 1990 | 34 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42577 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1985 | 9358 | 0.010 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1990 | 62 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1999 | 6853 | 0.000 |
Why?
|
| Cancer Vaccines | 1 | 1996 | 1042 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1990 | 618 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10745 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1990 | 313 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1986 | 76 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1999 | 10101 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1986 | 292 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1986 | 59 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1986 | 915 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1986 | 412 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11218 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1986 | 2168 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1993 | 4033 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1983 | 294 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 1529 | 0.000 |
Why?
|
| Octoxynol | 1 | 1982 | 76 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 13036 | 0.000 |
Why?
|
| Tetrodotoxin | 1 | 1983 | 243 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1982 | 112 | 0.000 |
Why?
|
| Cell Aggregation | 1 | 1982 | 238 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36570 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15912 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1982 | 655 | 0.000 |
Why?
|
| DNA, Single-Stranded | 1 | 1982 | 351 | 0.000 |
Why?
|
| Membrane Potentials | 1 | 1983 | 1085 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 939 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1982 | 973 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 13489 | 0.000 |
Why?
|
| Prognosis | 1 | 1999 | 29959 | 0.000 |
Why?
|
| Cricetinae | 1 | 1982 | 2416 | 0.000 |
Why?
|
| Dogs | 1 | 1982 | 3834 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1982 | 1189 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1982 | 1675 | 0.000 |
Why?
|
| Brain | 1 | 2002 | 27158 | 0.000 |
Why?
|
| Age Factors | 1 | 1988 | 18397 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1982 | 2255 | 0.000 |
Why?
|
| Kidney | 1 | 1982 | 7073 | 0.000 |
Why?
|